Smart Olfaction App to Reduce Relapse (NCT07007195)
An Innovative Digitally-Delivered Olfactory Method for Reducing Cigarette Cravings and Supporting Smoking Cessation
🩺 Plain-English Summary (8th-Grade Level)
The proposed project aims to refine and test a novel biobehavioral smoking cessation intervention that integrates the strategic application of olfactory stimulation to reduce cigarette craving with an established smartphone-based smoking cessation application. The specific aims of this study are: (1) refine the design and methodology of our olfactory stimulation delivery system (OSDS) and (2) compare, in a pilot randomized controlled trial (RCT), the effects of a smartphone based app for smoking cessation (Smart-T) with and without the OSDS on smoking cessation outcomes.
Who can join: Review the eligibility criteria below.
Location: RESTORE Laboratory: Research on Emotion, Substance Use Treatment Outcomes, Rehabilitation, and Empowerment — Houston, Texas
Age range: 18 Years
🧪 Interventions in This Study
- Ad Libitum Use followed by Instructed Use of the Inspire Device (DEVICE)
- Instructed Use followed by Ad Libitum Use of the Inspire Device (DEVICE)
- Smart-T Smoking Cessation App with the Inspire Device Condition (DEVICE)
- Smart-T Smoking Cessation App Without the Inspire Device Condition (DEVICE)
- Nicotine replacement therapy (NRT) (DRUG)
- Inspire Device (DEVICE)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- RESTORE Laboratory: Research on Emotion, Substance Use Treatment Outcomes, Rehabilitation, and Empowerment — Houston, Texas
📞 Contact the Study Coordinator
Phone: (713) 743-8056
Email: llgarey@central.uh.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Nicotine Dependence
- Targeting Orexin to Treat Nicotine Dependence — Belmont, Massachusetts
- Electronic Cigarettes and Reactivity to Smoking Cues — Belmont, Massachusetts
- Sex Differences in E-Cigarette Perception — New Haven, Connecticut
- NeuroControl of Nicotine Dependence — Columbia, Missouri
- Brain/Craving Response to Smoking Cues After Oral Nicotine Pouch Use — Los Angeles, California
- Orexin s Role in the Neurobiology of Substance Use Disorder — Baltimore, Maryland
Explore by condition: All Nicotine Dependence clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.